Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.

Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Lange E, Mellinger U, Palombo-Kinne E, Kuhl H.

Contraception. 2011 Aug;84(2):133-43. doi: 10.1016/j.contraception.2011.01.002. Epub 2011 Feb 21.

PMID:
21757054
2.

Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use.

Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Palombo-Kinne E, Mellinger U, Lange E, Kuhl H.

Horm Metab Res. 2010 May;42(5):358-63. doi: 10.1055/s-0030-1248263. Epub 2010 Mar 8.

PMID:
20213585
3.

Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use.

Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Palombo-Kinne E, Mellinger U, Lange E, Kuhl H.

Contraception. 2010 Jan;81(1):57-61. doi: 10.1016/j.contraception.2009.07.011.

PMID:
20004274
4.

Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.

Palombo-Kinne E, Schellschmidt I, Schumacher U, Gräser T.

Contraception. 2009 Apr;79(4):282-9. doi: 10.1016/j.contraception.2008.10.010. Epub 2008 Dec 16.

PMID:
19272497
5.

Expression of cytokine mRNA and protein in joints and lymphoid organs during the course of rat antigen-induced arthritis.

Pohlers D, Siegling A, Buchner E, Schmidt-Weber CB, Palombo-Kinne E, Emmrich F, Bräuer R, Kinne RW.

Arthritis Res Ther. 2005;7(3):R445-57. Epub 2005 Feb 17.

6.

Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression.

Rudolph I, Palombo-Kinne E, Kirsch B, Mellinger U, Breitbarth H, Gräser T.

Climacteric. 2004 Sep;7(3):301-11.

PMID:
15669555
7.

Minimal contribution of cell-bound antibodies to the immunoscintigraphy of inflamed joints with 99mTc-anti-CD4 monoclonal antibodies.

Kinne RW, Wolski A, Palombo-Kinne E, Wolf F, Emmrich F, Becker W.

Nuklearmedizin. 2002 Jun;41(3):129-34.

PMID:
12109032
8.

Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture--primary culture cells markedly differ from fourth-passage cells.

Zimmermann T, Kunisch E, Pfeiffer R, Hirth A, Stahl HD, Sack U, Laube A, Liesaus E, Roth A, Palombo-Kinne E, Emmrich F, Kinne RW.

Arthritis Res. 2001;3(1):72-6. Epub 2000 Nov 21.

9.

Macrophages in rheumatoid arthritis.

Kinne RW, Bräuer R, Stuhlmüller B, Palombo-Kinne E, Burmester GR.

Arthritis Res. 2000;2(3):189-202. Epub 2000 Apr 12. Review.

10.

123I-antileukoproteinase scintigraphy reveals microscopic cartilage alterations in the contralateral knee joint of rats with "monarticular" antigen-induced arthritis.

Meyer P, Burkhardt H, Palombo-Kinne E, Gründer W, Bräuer R, Stiller KJ, Kalden JR, Becker W, Kinne RW.

Arthritis Rheum. 2000 Feb;43(2):298-310.

11.

Cytokine gene activation in synovial membrane, regional lymph nodes, and spleen during the course of rat adjuvant arthritis.

Schmidt-Weber CB, Pohlers D, Siegling A, Schädlich H, Buchner E, Volk HD, Palombo-Kinne E, Emmrich F, Kinne RW.

Cell Immunol. 1999 Jul 10;195(1):53-65.

PMID:
10433797
12.

Rat antigen-induced arthritis: cartilage alterations assessed with iodine-123-antileukoproteinase.

Kinne RW, Meyer P, Gründer W, Buchner E, Palombo-Kinne E, Heinzel-Wieland R, Becker W, Wolf F, Kalden JR, Burkhardt H.

J Nucl Med. 1998 Sep;39(9):1638-45.

13.

The serine proteinase inhibitor antileukoproteinase specifically accumulates in normal but not in arthritic cartilage.

Burkhardt H, Meyer P, Buchner E, Palombo-Kinne E, Heinzel-Wieland R, Becker W, Wolf F, Kalden JR, Kinne RW.

J Rheumatol. 1997 Jun;24(6):1145-54.

PMID:
9195524
14.

T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices?

Kinne RW, Palombo-Kinne E, Emmrich F.

Biochim Biophys Acta. 1997 Apr 12;1360(2):109-41. Review. No abstract available.

15.

Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes.

Schmidt-Weber CB, Rittig M, Buchner E, Hauser I, Schmidt I, Palombo-Kinne E, Emmrich F, Kinne RW.

J Leukoc Biol. 1996 Aug;60(2):230-44.

PMID:
8773585
16.

Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes.

Kinne RW, Schmidt-Weber CB, Hoppe R, Buchner E, Palombo-Kinne E, Nürnberg E, Emmrich F.

Arthritis Rheum. 1995 Dec;38(12):1777-90.

PMID:
8849350
17.

Rat adjuvant arthritis: imaging with technetium-99m-anti-CD4 Fab' fragments.

Kinne RW, Becker W, Koscheck T, Kuhlmann J, Sharkey RM, Behr T, Palombo-Kinne E, Goldenberg DM, Wolf F, Emmrich F.

J Nucl Med. 1995 Dec;36(12):2268-75.

18.

Activation of synovial fibroblasts in rheumatoid arthritis.

Kinne RW, Palombo-Kinne E, Emmrich F.

Ann Rheum Dis. 1995 Jun;54(6):501-4. No abstract available.

19.

Joint uptake and body distribution of a technetium-99m-labeled anti-rat-CD4 monoclonal antibody in rat adjuvant arthritis.

Kinne RW, Becker W, Simon G, Paganelli G, Palombo-Kinne E, Wolski A, Bloch S, Schwarz A, Wolf F, Emmrich F.

J Nucl Med. 1993 Jan;34(1):92-8.

Supplemental Content

Loading ...
Support Center